Crozet BioPharma LLC
A US-based biotechnology consultancy focused on accelerating development of biological products for infectious diseases and cancer. The firm provides multidisciplinary development services including technical program management, process development, manufacturing oversight, analytical development, clinical operations, and regulatory support for vaccine and biologics programs.
Industries
Nr. of Employees
small (1-50)
Crozet BioPharma LLC
94 Jackson Road, Suite 108, Devens, MA 01434, USA
Products
Nipah Vaccine Candidate Development
Development of a vaccine candidate targeting the Nipah virus to prevent infection.
Ebola Vaccine Development Support
Support and advancement of the first successful Ebola vaccine towards regulatory licensure.
External Biological Product Development Team Services
Provision of external development teams to biopharmaceutical companies for biological product pipeline development.
Nipah Vaccine Candidate Development
Development of a vaccine candidate targeting the Nipah virus to prevent infection.
Ebola Vaccine Development Support
Support and advancement of the first successful Ebola vaccine towards regulatory licensure.
External Biological Product Development Team Services
Provision of external development teams to biopharmaceutical companies for biological product pipeline development.
Services
Provision of multidisciplinary external development teams to manage technical, clinical, regulatory and manufacturing activities for early-stage and pipeline biologics programs.
Technical services including process development, tech transfer, cGMP manufacturing oversight and quality control support for vaccine clinical supply.
Analytical method development, validation and GCLP testing of clinical specimens; development of assays to measure immune responses.
Provision of multidisciplinary external development teams to manage technical, clinical, regulatory and manufacturing activities for early-stage and pipeline biologics programs.
Technical services including process development, tech transfer, cGMP manufacturing oversight and quality control support for vaccine clinical supply.
Analytical method development, validation and GCLP testing of clinical specimens; development of assays to measure immune responses.
Expertise Areas
- Vaccine development and biologics
- Clinical trial management and operations
- Process development and technology transfer
- cGMP manufacturing oversight
Key Technologies
- Recombinant viral vector vaccine platforms
- Nonclinical in vivo safety and efficacy studies
- Immunogenicity and clinical immunology assays
- GCLP/analytical testing of clinical specimens
News & Updates
Announcement of a partnering agreement to advance development and manufacture of a single-dose Nipah virus vaccine, including oversight of manufacturing, nonclinical studies, immunoassays, and Phase 1/2 clinical trials.
Announcement of a partnering agreement to advance development and manufacture of a single-dose Nipah virus vaccine, including oversight of manufacturing, nonclinical studies, immunoassays, and Phase 1/2 clinical trials.